RFXAP antibody
Quick Overview for RFXAP antibody (ABIN6737417)
Target
See all RFXAP AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Specificity
- Recognizes human RFXAP.
- 
                                            Purification
- Affinity purified
- 
                                            Immunogen
- 
                        Recombinant human RFXAP.
 Type of Immunogen: Recombinant protein
- 
                                            Isotype
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- 
                        Approved: WB (1:1000 - 1:2000)
 Usage: Suitable for use in Western Blot. Western Blot: 1:1000-1:2000.
- 
                                            Comment
- 
                        Target Species of Antibody: Human 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- Lot specific
- 
                                            Buffer
- PBS, pH 7.4, 1 % BSA, 0.05 % sodium azide.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - RFXAP (Regulatory Factor X-Associated Protein (RFXAP))
- 
                                            Alternative Name
- RFXAP
- 
                                            Background
- 
                        Name/Gene ID: RFXAP
 Synonyms: RFXAP, RFX-associated protein
- 
                                            Gene ID
- 5994
- 
                                            UniProt
- O00287
 Target
- 
                    
 
                                     
                                     
                                    